News & Updates

Benralizumab beneficial to Asians with severe eosinophilic asthma

05 Apr 2024

The efficacy of benralizumab against severe eosinophilic asthma has been confirmed in an Asian population, with results consistent with the global data, as shown in the phase III MIRACLE trial.

Benralizumab beneficial to Asians with severe eosinophilic asthma

05 Apr 2024

Survival outcomes similar between minimally invasive interval debulking surgery and laparotomy

05 Apr 2024 by

A minimally invasive approach to interval debulking surgery appears to be just as effective as the use of an open technique for epithelial ovarian cancer, with no significant difference in overall survival (OS) when complete tumour resection is achieved, according to a study.

Survival outcomes similar between minimally invasive interval debulking surgery and laparotomy

05 Apr 2024

NSAIDs, combination therapies safe, effective for cataract surgery aftercare

05 Apr 2024

Nonsteroidal anti-inflammatory drugs (NSAIDs) and combination treatments provide a more effective and safer alternatives to corticosteroid in the postoperative management of patients who have undergone cataract surgery, according to a study.

NSAIDs, combination therapies safe, effective for cataract surgery aftercare

05 Apr 2024

$TDF ups fracture risk in older patients with chronic hepatitis B$

TDF ups fracture risk in older patients with chronic hepatitis B

05 Apr 2024 by

Tenofovir disoproxil fumarate (TDF) is associated with a higher fracture risk vs entecavir (ETV) after 2 years of treatment in older patients with chronic hepatitis B (CHB), a territory-wide cohort study has shown.

TDF ups fracture risk in older patients with chronic hepatitis B

05 Apr 2024

Rising prevalence of diabetic retinopathy increases the urgency of early screening

05 Apr 2024 by

A sizable proportion of patients with newly diagnosed type 2 diabetes mellitus (T2DM) do not understand the seriousness of eye complications related to the disease.

Rising prevalence of diabetic retinopathy increases the urgency of early screening

05 Apr 2024

Irritable bowel syndrome not a risk factor for Parkinson’s disease

04 Apr 2024

Individuals with irritable bowel syndrome (IBS) do not appear to be at increased risk of developing Parkinson’s disease compared with those who do not have IBS, according to the results of a Mendelian randomization analysis.

Irritable bowel syndrome not a risk factor for Parkinson’s disease

04 Apr 2024

Noninvasive device targets precancerous cervical lesions with minimal risk

04 Apr 2024 by

A novel device that integrates hexaminolevulinate (HAL) hydrochloride (HCl) with photodynamic therapy for the treatment of cervical histologic high-grade squamous intraepithelial lesions (HSIL) has shown good results in the global phase III APRICITY study, with lasting efficacy and an acceptable safety profile.

Noninvasive device targets precancerous cervical lesions with minimal risk

04 Apr 2024

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

New drug applications approved by US FDA as of 16-31 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

Endoscopic treatment shows therapeutic potential in severe duodenal polyposis

04 Apr 2024

In patients with severe duodenal polyposis, endoscopic treatment safely and effectively prevents cancer, offering a promising alternative to surgery, according to a study.

Endoscopic treatment shows therapeutic potential in severe duodenal polyposis

04 Apr 2024

Natural changes occurring in the gastrointestinal tract give rise to digestive symptoms in older adults

04 Apr 2024 by

Aging affects all the digestive functions and this is due to the natural changes affecting the gastrointestinal (GI) tract.

Natural changes occurring in the gastrointestinal tract give rise to digestive symptoms in older adults

04 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Benralizumab beneficial to Asians with severe eosinophilic asthma

Benralizumab beneficial to Asians with severe eosinophilic asthma

Survival outcomes similar between minimally invasive interval debulking surgery and laparotomy

Survival outcomes similar between minimally invasive interval debulking surgery and laparotomy

NSAIDs, combination therapies safe, effective for cataract surgery aftercare

NSAIDs, combination therapies safe, effective for cataract surgery aftercare

TDF ups fracture risk in older patients with chronic hepatitis B

TDF ups fracture risk in older patients with chronic hepatitis B

Rising prevalence of diabetic retinopathy increases the urgency of early screening

Rising prevalence of diabetic retinopathy increases the urgency of early screening

Irritable bowel syndrome not a risk factor for Parkinson’s disease

Irritable bowel syndrome not a risk factor for Parkinson’s disease

Noninvasive device targets precancerous cervical lesions with minimal risk

Noninvasive device targets precancerous cervical lesions with minimal risk

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Endoscopic treatment shows therapeutic potential in severe duodenal polyposis

Endoscopic treatment shows therapeutic potential in severe duodenal polyposis

Natural changes occurring in the gastrointestinal tract give rise to digestive symptoms in older adults

Natural changes occurring in the gastrointestinal tract give rise to digestive symptoms in older adults